Tine A. Baekdal
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.
Journal: Diabetes, obesity & metabolism
Published: July 30, 2024
A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous Injection.
Journal: The AAPS journal
Published: June 15, 2024
A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects.
Journal: Diabetes, obesity & metabolism
Published: December 18, 2023
Correction to: Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects.
Journal: Clinical pharmacokinetics
Published: June 28, 2023
Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects.
Journal: Clinical pharmacokinetics
Published: February 08, 2023
Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial.
Journal: Expert opinion on drug metabolism & toxicology
Published: July 22, 2021
Response to the letter from Horowitz et al. to the Editor relating to the publication 'Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes' by Dahl et al.
Journal: Diabetes, obesity & metabolism
Published: June 15, 2021
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials.
Journal: Clinical pharmacokinetics
Published: April 12, 2021
Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects.
Journal: Clinical pharmacokinetics
Published: March 30, 2021
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 26, 2021
Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 19, 2021
Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: August 11, 2020
Last Updated: 09/26/2026